BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT, LIXTW), a clinical-stage pharmaceutical company advancing LB-100, a first-in-class inhibitor of protein phosphatase 2A (PP2A), today announced that Geordan Pursglove, its chief executive officer, will present at the Spartan Capital Investor Conference 2025 in New York, on November 3, 2025, at 4 p.m. ET. Management will conduct one-on-one meetings with investors during the conferen ...

WINDSOR, Ontario, Oct. 29, 2025 (GLOBE NEWSWIRE) -- NEXE Innovations Inc. (“NEXE”, the “Company”, "we", or "our") (TSX.V: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a company focused on compostable materials and sustainable coffee solutions, announced today that it has received a repeat purchase order for ~250,000 BPI-certified compostable coffee pods from a North American office coffee services (OCS) and retail distributor. This follows an earlier delivery of 80,000 compostable coffee pods for three new SKUs on ...

MILPITAS, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- TurnOnGreen, Inc. (OTC: TOGI) (“TurnOnGreen” or the “Company”) and its power solutions subsidiary, Digital Power Corporation (“DPC”), today announced a major expansion of their telecommunications power product line, highlighted by a significant order from a global leader in network connectivity infrastructure. The order covers advanced power systems engineered for broadband, cable TV network, and data center applications, underscoring DPC’s growing presenc ...

SOMERSET, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Wednesday, November 12, 2025, to review third quarter 2025 results. During the webcast and conference call, senior leaders will provide an overview of Legend Biotech’s performance for the quarter. Investors and other interested parties may join the live audio webcast of the call via this weblink. A replay of ...

Feedonomics customers benefit from data optimized for and exported to key AI channels. Select BigCommerce customers can now access agentic checkout with PayPal's agentic commerce servicesAUSTIN, Texas, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Commerce (Nasdaq: CMRC), an open, intelligent ecosystem of technology solutions and the parent company of leading ecommerce platform BigCommerce and AI-enriched product feed management solution Feedonomics, today announced a new agentic commerce feature with seamless agentic ...

Media Release Pivotal TACTI-004 (KEYNOTE-F91) Phase III trial evaluating eftilagimod alfa (efti) in first line non-small cell lung cancer continues to build momentum and is recruiting patients at a growing number of activated clinical sites and countriesTrial in Progress poster for TACTI-004 presented at the World Conference on Lung Cancer (WCLC) 2025, where physician feedback continued to be encouragingPositive feedback received from the FDA regarding future late-stage clinical development of efti in first ...

New Hyperliquid Product Compounds Yield on 500,000 HYPE Staked by the CompanyLAGUNA HILLS, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed company dedicated to building a long-term strategic treasury of Hyperliquid’s native token, HYPE, today announced a strategic partnership with HyperEVM protocol Felix (“Felix”), marking a significant milestone in decentralized finance innovation. Under the newly signed HYPE As ...

MIAMI, NEW YORK and WASHINGTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Siebert Financial Corp. (NASDAQ: SIEB) today announced the opening of a Washington, D.C. office to support its expanding Capital Markets and Investment Banking team. Located at 3000 K Street, N.W., Suite 245, Washington, D.C., the new office will be led by Daniel M. Ondeck, Head of Institutional Sales, who works closely with Siebert’s investment bankers on origination and execution across public and private markets, as well as by newly appoin ...

CUPERTINO, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in Spartan Capital Securities Second Annual Investor Conference on November 3, 2025, in ...

SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults, today announced that it will host a webcast on Wednesday, November 5, 2025, at 8:30 a.m. EST to report its third quarter 2025 financial results and recent corporate highlights. To particip ...